Tag:
Soliris
Latest Headlines
Latest Headlines
How do the 12 priciest drugs in the U.S. stack up?
Last week, Vertex Pharmaceuticals ( $VRTX ) got FDA approval for Kalydeco, the first cystic fibrosis drug to address the disease's cause, rather than just its symptoms. The price tag: $294,000. But as
Novartis challenges Soliris patent in EU
Alexion Pharmaceuticals says in a filing that Novartis has filed an opposition to its European patent on Soliris (eculizumab), a treatment for paroxysmal nocturnal hemoglobinuria, a rare blood
